快速查,以识别抗病毒药物对持续和急性Coxsackievirus B3感染
Maria Del Mar Villanueva Guzman1,2, Natalie J LoMascolo1, Delaina May1
1Department of Microbiology and Immunology, Loyola University Chicago, Maywood, Illinois 60153, United States.
ACS infectious diseases
|November 26, 2024
概括
一种新的抗病毒药物Ro 5-3335在对抗急性和持续性Coxsackievirus B3 (CVB3) 感染方面表现有前途. 这种化合物对抗RNA病毒有效,准病毒的退出,并在目前不存在的地方提供潜在的解决方案.
科学领域:
- 病毒学 病毒学
- 抗病毒药物发现发现
- 分子生物学分子生物学
背景情况:
- 肠道病毒,包括Coxsackievirus B3 (CVB3),导致全球重大健康问题.
- 持续的CVB3感染,当病毒未被清除时,会带来治疗挑战.
- 目前对CVB3的抗病毒选择有限,需要开发新的药物.
研究的目的:
- 识别新型抗病毒化合物,有效应对急性和持续性CVB3感染.
- 为研究持久性CVB3感染建立一个模型系统.
- 评估相关细胞系中已识别的化合物的抗病毒潜力.
主要方法:
- 开发了一种用于持续性CVB3感染的PANC-1细胞模型,并使用Vero-E6细胞用于急性感染.
- 通过NIH的发育治疗方案 (DTP) 选了数千种化合物.
- 评估了杀伤性化合物的抗病毒活性,细胞毒性和作用机制.
主要成果:
- 鉴定了Ro 5-3335,一种二,作为一种强大的CVB3抑制剂,用于急性和持续性感染.
- Ro 5-3335在多种细胞类型中表现出抗病毒活性,细胞毒性最小.
- 病毒输出被确定为Ro 5-3335的抗病毒作用的潜在目标.
结论:
- 罗5-3335是治疗CVB3感染的有希望的候选人,包括持久形式.
- 该化合物对RNA病毒具有广泛的活性,但对DNA病毒没有.
- 对Ro 5-3335的进一步研究可能会导致肠道病毒感染的新疗法.
相关概念视频
Subviral Agents
Subviral agents are infectious entities that resemble viruses but lack one or more viral components, such as a capsid or essential replication machinery. These agents include viroids, prions, and satellites, each possessing distinct structural and functional characteristics that influence their mode of infection and replication.Viroids are the simplest subviral agents, consisting of circular, single-stranded RNA molecules without a protein coat. They exclusively infect plants, relying entirely...
Inhibitors Of Virion Release
Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...


